Laboratory test promises better rheumatoid arthritis therapy
This article was originally published in Clinica
Executive Summary
Prometheus Laboratories' forthcoming blood test for monitoring patient-response to the standard rheumatoid arthritis drug, methotrexate, could help doctors better tailor individual therapy in their patients, the company has reported.